Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1).
| Autor: | Schwartz, G. K.1 schwartg@mskcc.org, LoRusso, P. M.2, Dickson, M. A.1, Randolph, S. S.3, Shaik, M. N.4, Wilner, K. D.3, Courtney, R.3, O'Dwyer, P. J.5 |
|---|---|
| Zdroj: | British Journal of Cancer. 6/7/2011, Vol. 104 Issue 12, p1862-1868. 7p. 5 Charts, 1 Graph. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|